Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767)
09/2004
09/15/2004CN1528228A New method for inhibiting flu and preventing SARS
09/15/2004CN1528196A Broad-spectrum antibiotic antivirus complex chinese-western medicine-food dual-purpose nutrient for preventing and treating pharyngitis and preparing method thereof
09/15/2004CN1166678C Purine derivatives
09/15/2004CN1166668C Method for preparing substituted [1,4] diazepino (6,7,1-hi) indol-4-ones
09/15/2004CN1166667C Imidazoimidazoles and trizoles as anti-inflammatory agents
09/15/2004CN1166645C Bicyclic heterocyles, medicaments contg. these compounds, their use and methods for prodn. thereof
09/15/2004CN1166643C 4-phenyl-pyrimidine derivatives
09/15/2004CN1166629C Benzene sulfonamide compounds, its preparing method and medicinal compsns. contg. same
09/15/2004CN1166618C New selective retinoid agonists
09/15/2004CN1166408C Substrate tablet containing trimetzidine capable of long time controlled release after oral application
09/15/2004CN1166405C Antiviral agent in form of nose drops
09/15/2004CN1166401C Capsule for releiving cough and its preparation technology
09/15/2004CN1166400C Drug for treating cold
09/15/2004CN1166399C Medicine spray for treating throat disease and stomatopathy
09/15/2004CN1166394C Chinese medicine for treating pharynigitis and globus hystericus and its prepn
09/15/2004CN1166389C Inhalation liquor for treating common cold and its preparing process
09/15/2004CN1166388C Medicine for treating nosal inflammation
09/15/2004CN1166384C Medicine for relieving cough and asthma
09/14/2004US6790989 Interleukin-1 beta converting enzyme/caspase; for prolonging viability of organs/cells for transplantation; for treating inflammatory, autoimmnune and neurodegenerative diseases; prevention of ischemic injury
09/14/2004US6790941 Zinc finger protein derivatives and methods therefor
09/14/2004US6790867 Combination of flunixin or the meglumine salt with a fluorinated chloramphenicol or thiamphenicol derivative antibiotic such as florfenicol
09/14/2004US6790860 Pyrrolidine derivatives
09/14/2004US6790850 Thiazolo(4,5-d)pyrimidine compounds
09/14/2004US6790849 Methods and compositions using optically pure (-) cetirizine in combination with leukotriene inhibitors or decongestants
09/14/2004US6790465 Composition and method for treating snoring
09/14/2004CA2315826C Carboxyl acid substituted heterocycles as metalloproteinase inhibitors
09/10/2004WO2004075988A2 Methods of immunomodulation in animals
09/10/2004WO2004075920A1 Sustained-release pharmaceutical composition for lung administration
09/10/2004WO2004075896A1 Medicament comprising a highly potent long-lasting beta2-agonist in combination with other active ingredients
09/10/2004WO2004052847A3 Tricyclic steroid hormone nuclear receptor modulators
09/10/2004WO2004022128A3 Liquid aerosol formulations and aerosol generating devices and methods for generating aerosols
09/10/2004WO2004014352A3 Methods for treating carbonic anhydrase mediated disorders
09/10/2004WO2004009030A3 Angiogenesis inhibition by cephalotaxine alkaloids, derivatives, compositions and uses thereof
09/10/2004WO2003003979A3 Methods for the production of purified recombinant human uteroglobin for the treatment of inflammatory and fibrotic conditions
09/10/2004CA2517321A1 Medicament comprising a highly potent long-lasting beta2-agonist in combination with other active ingredients
09/09/2004US20040176601 Benzimisazo[4,5-f]isoquinolinone derivatives
09/09/2004US20040176595 Glucocorticoid receptor modulators
09/09/2004US20040176473 Methods for delivering compounds into a cell
09/09/2004US20040176456 Method of treatment for sexual dysfunction
09/09/2004US20040176443 Capsaicin receptor ligands
09/09/2004US20040176434 Pyrazoloanthrone derivatives as Jun N-terminal kinase inhibitors; diabetes; obesity
09/09/2004US20040176433 treatment of tumor necrosis factor mediated disorders; asthma; inflammatory bowel disease; arthritis
09/09/2004US20040176422 Heteroarylheteroalkylamine derivatives and their use as inhibitors of nitric oxide synthase
09/09/2004US20040176421 such as 1,4-Bis-{N-[3-(3-aminomethylphenylproplonyl)-2-methoxycarbonylpyrrolidin-4-yl]aminocarbonyloxy}-2-butyne dihydrochloride; for treatment of asthma, allergic conjunctivitis, allergic rhinitis, psoriasis, and ulcerative colitis
09/09/2004US20040176419 particularly chronic obstructive pulmonary disease (COPD), asthma or a related pulmonary disease such as chronic bronchitis or allergic rhinitis
09/09/2004US20040176417 Substituted 2-thio-3, 5-dicyano-4-phenyl-6-aminopyridines and their use as adenosine receptor-selective ligands
09/09/2004US20040176411 especially useful for treating asthma and/or rhinitis; example compound N-[[[2-[4-(3,4-dichlorophenoxy)-1-piperidinyl]ethyl]amino]carbonyl]-4-methyl-benzenesulfonamide
09/09/2004US20040176400 Fused pyrimidines as antagonists of the corticotropin releasing factor (crf)
09/09/2004US20040176389 Piperazine oxime dervatives having nk-1 receptor antagonistic activity
09/09/2004US20040176386 Compounds
09/09/2004US20040176382 treatment of inflammation, proliferative diseases, and certain cardiovascular disorders as well as Alzheimer's disease;
09/09/2004US20040176365 1,8-Naphthyridin-2(1H)-one derivatives; antiasthmatic, antihistamine, and bronchodilator agents; nontoxic, side effect reduction
09/09/2004US20040176363 N-Acylpiperazine derivatives; cardiovascular disorders; anticoagulants
09/09/2004US20040176353 Derivatives of pyrimido[6,1-a]isoquinolin-4-one
09/09/2004US20040176320 Use of at least one glycoinhibitor substance
09/09/2004US20040176252 Well tolerated; intracellularly increasing cAMP; antiasthmatics, antiinflammatories: regulation of eosinophiles activation and degranulation
09/09/2004US20040175803 Interferon-alpha induced gene
09/09/2004US20040175422 excellent storage stability and little tendency to change the release rate of the pharmacologically active substance even after long-term storage; matrix comprising low-melting-point substance and pH-independent water-insoluble polymer
09/09/2004US20040175419 controlling crystallization parameters of active ingredient to achieve increased compactability; compacting the active ingredient into a tablet
09/09/2004US20040175363 Defective recombinant adenovirus; treatment of neurodenerative, cardiovascular, brain, genetic, nervous system and respiratory system disorders; Alzheimer's, Parkinson's, amyotrophic lateral sclerosis (ALS), atherosclerosis, and/or trisomy 2; adult respiratory distress syndrome; anticarcinogenic agents
09/08/2004EP1454901A1 Piperazine compounds and pharmaceutical compositions containing them.
09/08/2004EP1454898A1 Novel phenylalanine derivative
09/08/2004EP1454897A1 PYRAZOLOPYRIMIDINONE DERIVATIVES HAVING PDE7−INHIBITORY ACTIVITY
09/08/2004EP1453909A1 Cereal beta glucan compositions, methods of preparation and uses thereof
09/08/2004EP1453832A1 Ring fused pyrazole derivatives
09/08/2004EP1453829A1 Sulfonamido substituted imidazopyridines
09/08/2004EP1453825A1 N-ureido-piperidines as antagonists viii for ccr-3 receptor
09/08/2004EP1453820A1 Substituted 6h-dibenzo c,h]chromenes as estrogenic agents
09/08/2004EP1453810A1 Substituted 4-phenyltetrahydroisoquinolines, method for the production thereof, the use thereof as medicaments, in addition to a medicament containing same
09/08/2004EP1453806A1 Aminotetralin derivatives as muscarinic receptor antagonist
09/08/2004EP1453805A1 4-piperidinyl alkylamine derivatives as muscarinic receptor antagonists
09/08/2004EP1453804A2 Ccr-3 receptor antagonists vii
09/08/2004EP1453801A1 Substituted 2-amino-cycloalkanecarboxamides and their use as cysteine protease inhibitors
09/08/2004EP1453798A2 (20s)-1alpha-hydroxy-2-methylene-19-nor-bishomopregnacalciferol and its uses
09/08/2004EP1453782A2 Substituted phenyl naphthalenes as estrogenic agents
09/08/2004EP1453777A1 Functionalized higher diamondoids
09/08/2004EP1453743A2 Pharmaceutical product with an adsorbent
09/08/2004EP1453548A2 Compositions for and methods of treating and preventing sirs/sepsis
09/08/2004EP1453547A2 Adeno-associated virus (aav) serotype 8 sequences, vectors containing same, and uses therefor
09/08/2004EP1453545A1 Water-soluble polymer conjugates of retinoic acid
09/08/2004EP1453522A1 Methods for treatment or prophylaxis of aldosterone-mediated pathogenic effectgs in a subject using an epoxy-steroidal aldosterone antagonist
09/08/2004EP1453515A2 Method to treat cystic fibrosis
09/08/2004EP1453514A1 Piperazine derivatives for use as ccr-3 receptor antagonists in the treatment of asthma
09/08/2004EP1453510A2 Neurotransmitter balance chemotherapy
09/08/2004EP1453508A1 Tempamine compositions and use against cellular oxidative damage
09/08/2004EP1453498A1 Use of a cysteine-containing substance to increase the ventilatory activity and erythropoietin production
09/08/2004EP1453497A1 Use for the treatment of gastroesophageal reflux disease
09/08/2004EP1453493A2 Reversible proton pump inhibitors for the treatment of airway disorders
09/08/2004EP1453481A1 Reverse-micellar delivery system for controlled transportation and enhanced absorption of agents
09/08/2004EP1345603A4 (halo-benzo carbonyl)heterocyclo fused phenyl p38 kinase inhibiting agents
09/08/2004EP1292281B1 Novel tiotropium-containing inhalation powder
09/08/2004EP1289972B1 Serine protease inhibitors
09/08/2004EP1289950B1 Serine protease inhibitors
09/08/2004EP1176971B1 Use of phyllanthus for treating chronic inflammatory and fibrotic processes
09/08/2004EP1122243B1 Novel imidazoles with anti-inflammatory activity
09/08/2004EP1079839B1 Therapeutic anti-cold agent containing isomalt as an active ingredient
09/08/2004EP0994876B1 Quaternary ammonium compounds as tachykinin antagonists
09/08/2004EP0623126B1 Imidazole derivatives and their use as cytokine inhibitors
09/08/2004CN1527840A Use of CD 25 binding molecules in steroid-resistant patients
09/08/2004CN1527838A Anti-inflammatory 17. beta-carbothioate ester derivatives of androstane with a cyclic ester group in position 17. alpha